OIG Finds Significant Rise In Part D Spending On Compounded Drugs

Inside Health Policy‎ - 10 hours ago

Medicare Part D spending on compounded drugs grew from $70.2 million in 2006 to $508.7 million in 2015, and topical drugs accounted for an outsized portion